Area of expertise
Specialty
Oncology
Subspecialty
Medical Oncology
Diseases
Skin Cancers, Pancreatic Cancer, Gastric Cancer, Biliary Tract Cancer, Liver Cancer, Bowel Cancer, Small Bowel Cancer, Gastrointestinal Cancers
Procedures Performed
Immunotherapy
Chemotherapy
Targeted Therapy
Experience
CMO and Global Head of Drug Development, Ellipses Pharma
London, United Kingdom. From 2022
Clinical Lead, Oncology Service Line, HCA International
London, United Kingdom. 2015 - 2022
Professor, University College London
London, United Kingdom. 2011 - 2022
Executive Medical Director, Sarah Cannon Research Institute
London, United Kingdom. 2010 - 2022
Team Leader, Clinical Drug Development, University of New South Wales
Kensington, Australia. 2008 - 2010
Education
MD: Martin Luther University Halle-Wittenberg, Hannover Medical School
2000
Biography
Dr. Tobias Arkenau is a world-renowned expert in the clinical and translational development of new cancer treatments. He has over 20 years of experience and has worked on more than 300 oncology trials at all stages of development. Dr. Arkenau has a broad range of experience in treating patients with gastrointestinal cancers (bowel, stomach, pancreas, biliary tree, liver) and skin cancers using various treatments, such as immunotherapy, targeted therapy, and chemotherapies. Dr. Arkenau's caree
Affiliations
German Cancer Society
American Society of Clinical Oncology
American Association for Cancer Research
European Society for Medical Oncology
Publications
Dr. Tobias Arkenau has more than 200 publications